Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-01 Sale |
2021-06-03 6:28 pm |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
7,500 | $26.83 | $201,221 | 22,596 (Direct) |
View |
2021-04-28 Sale |
2021-04-30 5:49 pm |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
10,014 | $25.76 | $257,983 | 30,096 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-05-17 Option Award |
2022-05-19 4:59 pm |
N/A 2032-05-16 |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
25,800 | $0 | 25,800 (Direct) |
View |
2021-06-01 Exercise |
2021-06-03 6:28 pm |
N/A 2026-11-21 |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
7,500 | $0 | 22,596 (Direct) |
View |
2021-06-01 Exercise |
2021-06-03 6:28 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
7,500 | $8.39 | 22,596 (Direct) |
View |
2021-05-26 Option Award |
2021-05-28 5:29 pm |
N/A 2031-05-25 |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
35,000 | $0 | 35,000 (Direct) |
View |
2021-04-28 Exercise |
2021-04-30 5:49 pm |
N/A 2026-11-21 |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
10,014 | $0 | 30,096 (Direct) |
View |
2021-04-28 Exercise |
2021-04-30 5:49 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
10,014 | $8.39 | 30,096 (Direct) |
View |
2021-02-07 Option Award |
2021-02-08 9:35 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-16 Option Award |
2020-12-18 6:08 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
25,000 | $0 | 25,000 (Direct) |
View |